$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Amino lipids and methods for the delivery of nucleic acids 원문보기

IPC분류정보
국가/구분 United States(US) Patent 등록
국제특허분류(IPC7판)
  • C07D-317/28
  • A61K-009/127
  • C07D-319/06
출원번호 US-0123307 (2009-10-09)
등록번호 US-9139554 (2015-09-22)
국제출원번호 PCT/US2009/060251 (2009-10-09)
§371/§102 date 20110701 (20110701)
국제공개번호 WO2010/042877 (2010-04-15)
발명자 / 주소
  • Hope, Michael J.
  • Semple, Sean C.
  • Chen, Jianxin
  • Madden, Thomas D.
  • Cullis, Pieter R.
  • Ciufolini, Marco A.
  • Mui, Barbara Low Shoud
출원인 / 주소
  • Tekmira Pharmaceuticals Corporation
대리인 / 주소
    Viksnins Harris & Padys PLLP
인용정보 피인용 횟수 : 6  인용 특허 : 191

초록

The present invention provides superior compositions and methods for the delivery of therapeutic agents to cells. In particular, these include novel lipids and nucleic acid-lipid particles that provide efficient encapsulation of nucleic acids and efficient delivery of the encapsulated nucleic acid t

대표청구항

1. An amino lipid having the structure:

이 특허에 인용된 특허 (191)

  1. Tkachuk Zenovy (Kiev SUX) Kvasyuk Eugeny (Kiev SUX) Matsuka Gennady (Kiev SUX) Mikhailopulo Igor (Kiev SUX), (2′-5′) oligoadenylate analogues useful as inhibitors of host-v5.-graft response.
  2. Huynh Dinh Tam (Croissy/Seine FRX) Gouyette Catherine (Vanves FRX) Igolen Jean (Le Mesnil St. Denis FRX), 2,N6-disubstituted and 2,N6-trisubstituted adenosine-3′-phosphoramidites.
  3. Buhr Chris A. (Daly City CA) Matteucci Mark (Burlingame CA), 2\modified nucleoside and nucleotide compounds.
  4. Suhadolnik Robert J. (Roslyn PA) Pfleiderer Wolfgang (Constance DEX), 2′,5′-phosphorothioate oligoadenylates and their covalent conjugates with polylysine.
  5. Montgomery John A. (Birmingham AL) Secrist ; III John A. (Birmingham AL), 2′-deoxy-4′-thioribonucleosides and their antiviral activity.
  6. Usman Nassim (Boulder CO) Karpeisky Alexander (Boulder CO) Beigelman Leonid (Longmont CO) Modak Anil (Boulder CO), 2′deoxy-2′-alkylnucleotide containing nucleic acid.
  7. Cook Philip D. (Carlsbad CA) Delecki Daniel J. (Radnor PA) Guinosso Charles (Vista CA), Acyclic nucleoside analogs and oligonucleotide sequences containing them.
  8. Summerton James E. (Corvallis OR) Weller Dwight D. (Corvallis OR) Stirchak Eugene P. (Corvallis OR), Alpha-morpholino ribonucleoside derivatives and polymers thereof.
  9. David Aaron Schwartz ; William J. Daily ; Brian Patrick Dwyer ; Kumar Srinivasan ; Bob Dale Brown, Amide-based cationic lipids.
  10. Schwartz David Aaron ; Daily William J. ; Dwyer Brian Patrick ; Srinivasan Kumar ; Brown Bob Dale, Amide-based cationic lipids.
  11. Schwartz, David Aaron; Daily, William J.; Dwyer, Brian Patrick; Srinivasan, Kumar; Brown, Bob Dale, Amide-based cationic lipids.
  12. Schwartz David Aaron ; Dwyer Brian Patrick ; Daily William J. ; Srinivasan Kumar ; Brown Bob Dale, Amide-based oligomeric cationic lipids.
  13. Agrawal Sudhir (Shrewsbury MA) Tang Jin-Yan (Shrewsbury MA), Aminoalkylphosphorothioamidate oligonucleotide deratives.
  14. Agrawal Sudhir (Shrewsbury MA) Tang Jin-Yan (Shrewsbury MA), Aminoalkylphosphotriester oligonucleotide derivatives.
  15. Baker Brenda ; Bennett C. Frank ; Anderson Kevin P., Antisense inhibition of ICAM-1, E-selectin, and CMV IE1/IE2.
  16. Baracchini Edgardo ; Bennett C. Frank ; Dean Nicholas M., Antisense oligonucleotide modulation of multidrug resistance-associated protein.
  17. Switzer Christopher (Moreno Valley CA), Antisense oligonucleotides comprising 5-aminoalkyl pyrimidine nucleotides.
  18. Galli Rachel L. ; Lieberman Harris R. ; Fine Richard E., Antisense oligonucleotides specific for the muscarinic type 2 acetylcholine receptor MRNA.
  19. Morrison Richard S., Antisense oligonucleotides which reduce expression of the FGFRI gene.
  20. Rubenstein Marvin (Skokie IL), Antisense polynucleotide inhibition of epidermal human growth factor receptor expression.
  21. Shewmaker Christine K. ; Kridl Jean C. ; Hiatt William R. ; Knauf Vic, Antisense regulation of gene expression in plant cells.
  22. Considine John,GB2 ITX B12 8LN ; Bunce Colin John,GB6 ITX G51 3NX, Apparatus for removing tumours from hollow organs of the body.
  23. De Mesmaeker Alain (Kaenerkinden CHX) Lebreton Jacques (Marseilles FRX) Waldner Adrian (Allschwil CHX) Cook Phillip D. (Carlsbad CA), Backbone modified oligonucleotide analogs.
  24. Cook Phillip D. (Carlsbad CA) Sanghvi Yogesh S. (San Marcos CA) Morvan Francois (Montpellier FRX), Backbone modified oligonucleotide analogs and solid phase synthesis thereof.
  25. Cook Phillip D. (Carlsbad CA) Sanghvi Yogesh S. (San Marcos CA) Vasseur Jean J. (San Marcos CA) Debart Francoise (Montpellier FRX), Backbone modified oligonucleotide analogues.
  26. Sanghvi Yogesh S. (San Marcos CA) Cook Phillip D. (Vista CA), Backbone-modified oligonucleotide analogs and preparation thereof through radical coupling.
  27. Leumann Christian (Zurich CHX), Bicyclic nucleosides, oligonucleotides, process for their preparation and intermediates.
  28. Leumann Christian (Zurich CHX), Bicyclic nucleosides, oligonucleotides, process for their preparation and intermediates.
  29. Holland John W.,AUX ; Madden Thomas D.,CAX ; Cullis Pieter R.,CAX, Bilayer stabilizing components and their use in forming programmable fusogenic liposomes.
  30. Matteucci Mark D. (Burlingame CA) Cao Xiaodong (Carlsbad CA), Binding compentent oligomers containing unsaturated 3′,5′and 2′,5′linkages.
  31. Spielvogel Bernard F. (Raleigh NC) Sood Anup (Durham NC) Hall Iris H. (Chapel Hill NC) Ramsay Shaw Barbara (Durham NC), Boronated nucleoside, nucleotide and oligonucleotide compounds, compositions and methods for using same.
  32. Schwartz David Aaron ; Brown Bob Dale ; Dwyer Brian Patrick, Carbamate-based cationic lipids.
  33. Schwartz, David Aaron; Brown, Bob Dale; Dwyer, Brian Patrick, Carbamate-based cationic lipids.
  34. Altmann Karl-Heinz (Basel CHX) Imwinkelried Rene (Brig-Glis CHX) Eschenmoser Albert (Kusnacht CHX), Carbocyclic nucleosides containing bicyclic rings, oligonucleotides therefrom, process for their preparation, their use.
  35. Altmann Karl-Heinz (Basel CHX) Imwinkelried Rene (Brig-Glis CHX) Eschenmoser Albert (Kusnacht CHX), Carbocyclic nucleosides containing bicyclic rings, oligonucleotides therefrom, process for their preparation, their use.
  36. Eibl, Hansjorg; Wang, Jinkang; Zhang, Yi Lin, Cationic lipids.
  37. Gebeyehu Gulilat (Silver Spring MD) Jessee Joel A. (Mt. Airey MD) Ciccarone Valentina C. (Gaithersburg MD) Hawley-Nelson Pamela (Silver Spring MD) Chytil Anna (Nashville TN), Cationic lipids.
  38. Heyes, James; MacLachlan, Ian; Palmer, Lorne R., Cationic lipids and methods of use.
  39. Felgner, Philip L.; Kumar, Raj; Basava, Channa; Border, Richard C.; Hwang-Felgner, Jiin-Yu, Cationic lipids for intracellular delivery of biologically active molecules.
  40. Cullis, Pieter R.; Chen, Tao; Fenske, David B.; Palmer, Lorne R.; Wong, Kim, Cationic peg-lipids and methods of use.
  41. Semple Sean C.,CAX ; Klimuk Sandra K.,CAX ; Harasym Troy,CAX ; Hope Michael J.,CAX ; Ansell Steven M.,CAX ; Cullis Pieter,CAX ; Scherrer Peter,CAX ; Debeyer Dan,CAX, Charged therapeutic agents encapsulated in lipid particles containing four lipid components.
  42. Bertsch-Frank Birgit (Rheinfelden DEX) Klasen Claas-Juergen (Freigericht DEX) Lieser Thomas (Hapau DEX) Mueller Klaus (Hasselroth DEX) Bewersdorf Martin (Gelnhausen DEX), Coated sodium percarbonate particles, a process for their production and detergent, cleaning and bleaching compositions.
  43. Jessee Joel A., Composition and methods for transfecting eukaryotic cells.
  44. Jessee Joel A. (Mt. Airy MD), Composition and methods for transfecting eukaryotic cells.
  45. Semple, Sean C.; Klimuk, Sandra K.; Harasym, Troy O.; Dos Santos, Nancy; Ansell, Steven M.; Cullis, Pieter R; Hope, Michael J.; Scherrer, Peter; McIntosh, Deirdre; Wong, Kim F.; Maurer, Norbert, Composition containing small multilamellar oligodeoxynucleotide-containing lipid vesicles.
  46. MacLachlan, Ian; Judge, Adam; Heyes, James; Palmer, Lorne, Compositions comprising immunostimulatory siRNA molecules and DLinDMA or DLenDMA.
  47. Ansell Steven Michial,CAX ; Mui Barbara,CAX ; Hope Michael,CAX, Compositions for the introduction of polyanionic materials into cells.
  48. Ansell Steven Michial,CAX ; Mui Barbara,CAX ; Hope Michael,CAX, Compositions for the introduction of polyanionic materials into cells.
  49. Cook Phillip D. (San Marcos CA) Teng Kelly (San Diego CA), Conjugated 4′-desmethyl nucleoside analog compounds.
  50. Cook Phillip D. (Carlsbad CA) Baschang Gerhard (Bettingen CHX), Cyclobutyl oligonucleotide surrogates.
  51. Eley, Crispin G. S.; Schmidt, Paul G.; Fujii, Gary, Delivery vehicles with amphiphile-associated active ingredient.
  52. Spencer James T. (Syracuse NY) Dowben Peter A. (Dewitt NY) Kim Yoon G. (Syracuse NY), Deposition of boron-containing films from decaborane.
  53. Schwartz David Aaron ; Dwyer Brian Patrick ; Daily William J. ; Srinivasan Kumar ; Brown Bob Dale, Dimeric cationic lipids.
  54. Baxter Anthony D. (Northwich GB2) Baylis Eric K. (Stockport GB2) Collingwood Stephen P. (Westhoughton GB2) Taylor Roger J. (Stretford GB2) De Mesmaeker Alain (Kanerkinden CHX) Schmit Chantal (Basel C, Dinucleoside phosphinates and their pharmaceutical compositions.
  55. Suhadolnik Robert J. (Roslyn PA) Pfleiderer Wolfgang (Konstanz DEX), Dual action 2′,5′-oligoadenylate antiviral derivatives and uses thereof.
  56. Pitts ; Jr. M. Michael (6651 N. Campbell Ave. ; No. 171 Tucson AZ 85718), Electrostatic device for water treatment.
  57. Suhadolnik Robert J. (Roslyn PA) Pfleiderer Wolfgang (Constance DEX), Encapsulated 2′,5′-phosphorothioate oligoadenylates.
  58. Froehler Brian (Belmont CA) Matteucci Mark (Burlingame CA), Enhanced triple-helix and double-helix formation with oligomers containing modified purines.
  59. Shih PoJen (Columbia MD) Hawley-Nelson Pamela (Silver Spring MD) Jessee Joel A. (Mt. Airy MD), Enhancement of lipid cationic transfections in the presence of serum.
  60. Felgner Philip L. (Rancho Santa Fe CA) Wolff Jon Asher (Madison WI) Rhodes Gary H. (Leucadia CA) Malone Robert Wallace (Davis CA) Carson Dennis A. (Del Mar CA), Generation of antibodies through lipid mediated DNA delivery.
  61. Ansell Steven Michial,CAX, Glycosylated protein-liposome conjugates and methods for their preparation.
  62. Chowrira Bharat (Boulder CO) McSwiggen James (Boulder CO), Hairpin ribozymes.
  63. Geho W. Blair (Wooster OH) Lau John R. (Wooster OH), Hepatocyte Directed Vesicle delivery system.
  64. Cook Phillip D. (Carlsbad CA) Sanghvi Yogesh S. (Carlsbad CA), Heteroatomic oligonucleoside linkages.
  65. Teng Kelly (San Diego CA) Sanghvi Yogesh S. (San Marcos CA) Cook Phillip Dan (San Marcos CA), Heteroatomic oligonucleoside linkages.
  66. Haces Alberto (Gaithersburg MD) Ciccarone Valentina C. (Gaithersburg MD), Highly packed polycationic ammonium, sulfonium and phosphonium lipids.
  67. Rogers Thomas E. (Manchester MO) Gray Steven H. (Ellisville MO) Devadas Balekudru (Chesterfield MO) Adams Steven P. (St. Charles MO), Improved probes using nucleosides containing 3-dezauracil analogs.
  68. Cohen Jack S. (Bethesda MD) Neckers Len (Bethesda MD) Stein Cy (Gaithersburg MD) Loke She L. (Wheaton MD) Shinozuka Kazuo (Kazo JPX), Inhibitors for replication of retroviruses and for the expression of oncogene products.
  69. Cohen Jack S. (Bethesda MD) Neckers Len (Bethesda MD) Stein Cy (Gaithersburg MD) Loke She L. (Wheaton MD) Shinozuka Kazuo (Kazo JPX), Inhibitors for replication of retroviruses and for the expression of oncogene products.
  70. Cohen Jack S. (Bethesda MD) Neckers Len (Bethesda MD) Stein Cy (Gaithersburg MD) Loke Shee L. (Wheaton MD) Shinozuka Kazuo (Kazo JPX), Inhibitors for replication of retroviruses and for the expression of oncogene products.
  71. Agrawal Sudhir (Shrewsbury MA) Tang Jin-Yan (Shrewsbury MA), Linear aminoalkylphosphoramidate oligonucleotide derivatives.
  72. Manoharan, Muthiah; Rajeev, Kallanthottathil G.; Akinc, Akin; Jayaprakash, Narayanannair K.; Jayraman, Muthusamy; Maier, Martin, Lipid containing formulations.
  73. MacLachlan, Ian; Ambegia, Ellen Grace; Heyes, James, Lipid encapsulated interfering RNA.
  74. MacLachlan, Ian; Palmer, Lorne R.; Heyes, James, Lipid encapsulated interfering RNA.
  75. Yaworski, Edward; Lam, Kieu; Jeffs, Lloyd; Palmer, Lorne; MacLachlan, Ian, Lipid formulations for nucleic acid delivery.
  76. Fountain Michael W. (Plainsboro NJ) Weiss Steven J. (Heightstown NJ) Popescu Mircea C. (Plainsboro NJ), Lipid vesicles prepared in a monophase.
  77. Semple, Sean C.; Klimuk, Sandra K.; Harasym, Troy; Hope, Michael J.; Ansell, Steven M.; Cullis, Pieter; Scherrer, Peter; Debeyer, Dan, Lipid-encapsulated polyanionic nucleic acid.
  78. Semple,Sean C.; Klimuk,Sandra K.; Harasym,Troy; Hope,Michael J.; Ansell,Steven M.; Cullis,Pieter; Scherrer,Peter; Debeyer,Dan, Lipid-encapsulated polyanionic nucleic acid.
  79. Bally Marcel B.,CAX ; Zhang Yuan-Peng,CAX ; Reimer Dorothy L.,CAX ; Wheeler Jeffery J.,CAX, Lipid-nucleic acid particles prepared via a hydrophobic lipid-nucleic acid complex intermediate and use for gene transf.
  80. Wheeler Jeffery J.,CAX ; Bally Marcel B.,CAX ; Zhang Yuan-Peng,CAX ; Reimer Dorothy L.,CAX ; Hope Michael,CAX ; Cullis Pieter R.,CAX ; Scherrer Peter,CAX, Lipid-nucleic acid particles prepared via a hydrophobic lipid-nucleic acid complex intermediate and use for gene transf.
  81. Wheeler, Jeffery J.; Bally, Marcel B.; Zhang, Yuan-Peng; Reimer, Dorothy L.; Hope, Michael; Cullis, Pieter R.; Scherrer, Peter, Lipid-nucleic acid particles prepared via a hydrophobic lipid-nucleic acid complex intermediate and use for gene transfer.
  82. Wheeler,Jeffery J.; Bally,Marcel B.; Zhang,Yuan Peng; Reimer,Dorothy L.; Hope,Michael; Cullis,Pieter R.; Scherrer,Peter, Lipid-nucleic acid particles prepared via a hydrophobic lipid-nucleic acid complex intermediate and use for gene transfer.
  83. Ansell Steve (Vancouver CAX), Lipophilic drug derivatives for use in liposomes.
  84. Behr Jean-Paul (Strasbourg FRX) Loeffler Jean-Philippe (Strasbourg FRX), Lipopolyamines, their preparation and their use.
  85. MacLachlan, Ian; Jeffs, Lloyd Brian; Palmer, Lorne R.; Giesbrecht, Cory; Giesbrecht, legal representative, Noelle, Liposomal apparatus and manufacturing methods.
  86. Rose John K. (Guilford CT), Liposomal transfection of nucleic acids into animal cells.
  87. Papahadjopoulos Demetrios P. (Lafayette CA) Heath Timothy D. (San Francisco CA), Liposome conjugates and diagnostic methods therewith.
  88. Martin Francis J. (San Francisco CA) Morano Jacqueline K. (Mountain View CA), Liposome extrusion method.
  89. Rahman Yueh-Erh (Downers Grove IL) Cerny Elizabeth A. (Downers Grove IL), Liposome-encapsulated actinomycin for cancer chemotherapy.
  90. Woodle Martin C. (Menlo Park CA) Martin Francis J. (San Francisco CA) Yau-Young Annie (Los Altos CA) Redemann Carl T. (Walnut Creek CA), Liposomes with enhanced circulation time.
  91. Guo Luke S. S. (Lafayette CA) Redemann Carl T. (Walnut Creek CA) Radhakrishnan Ramachandran (Palo Alto CA) Yau-Young Annie (Los Altos CA), Liposomes with enhanced retention on mucosal tissue.
  92. Epand Richard M. (Hamilton CAX) Bottega Remo (Ancaster,both of PA CAX) Huang Leaf (Upper St. Claim PA), Method for delivering nucleic acids into cells.
  93. Deamer David W. (Woodland CA), Method for encapsulating materials into liposomes.
  94. Benner Steven A. (Hadlaubstrasse 151 CH-8006 Zurich CHX), Method for incorporating into a DNA or RNA oligonucleotide using nucleotides bearing heterocyclic bases.
  95. Becherer Kathleen ; Dattagupta Nanibhushan ; Naidu Yathi M., Method for inhibiting cellular proliferation using antisense oligonucleotides to gp130 mRNA.
  96. Papahadjopoulos Demetrios P. (78 Heathwood Williamsville NY 14221) Szoka ; Jr. Francis C. (375 Leroy Ave. Buffalo NY 14214), Method of encapsulating biologically active materials in lipid vesicles.
  97. Szoka ; Jr. Francis C. (76 Summit St. Waltham MA 02154) Papahadjopoulos Demetrios P. (3170 Condit St. Lafayette CA 94549), Method of inserting DNA into living cells.
  98. Sears Barry D. (43 Bay State Rd. Boston MA 02215), Method of preparing a controlled-release pharmaceutical preparation, and resulting composition.
  99. Wheeler, Jeffrey; Bally, Marcel B.; Zhang, Yuan-Peng; Reimer, Dorothy L.; Hope, Michael, Method of preventing aggregation of a lipid:nucleic acid complex.
  100. Alul Rushdi (Columbia MD), Methods and compositions for sequence-specific hybridization of RNA by 2′-5′oligonucleotides.
  101. Wheeler Jeffery J.,CAX ; Hope Michael,CAX ; Cullis Pieter R.,CAX ; Bally Marcel B.,CAX, Methods for encapsulating plasmids in lipid bilayers.
  102. Wheeler, Jeffery J.; Hope, Michael; Cullis, Pieter R.; Bally, Marcel B., Methods for encapsulating plasmids in lipid bilayers.
  103. Maurer,Norbert; Wong,Kim F; Cullis,Pieter R., Methods for preparation of lipid-encapsulated therapeutic agents.
  104. Wang Jinkang ; Zhang Yi-Lin, Methods of delivery using cationic lipids and helper lipids.
  105. Lam,Angela M. I.; Palmer,Lorne R.; Cullis,Pieter R., Methods of enhancing SPLP-mediated transfection using endosomal membrane destabilizers.
  106. Martin Francis J. (San Francisco CA) Woodle Martin C. (Menlo Park CA) Redemann Carl (Walnut Creek CA) Yau-Young Annie (Palo Alto CA) Radhakrishnan Ramachandran (Fremont CA), Microreservoir liposome composition and method.
  107. Matteucci Mark (Burlingame CA) Jones Robert J. (Daly City CA) Munger John (San Francisco CA), Modified internucleoside linkages having one nitrogen and two carbon atoms.
  108. Beaton Graham (Boulder CO) Fisher Eric F. (Boulder CO), Modified oligonucleotides and intermediates useful in nucleic acid therapeutics.
  109. MacLachlan, Ian; Judge, Adam, Modified siRNA molecules and uses thereof.
  110. Gaucheron,Jerome; Wong,Kim; Cullis,Pieter, Multivalent cationic lipids and methods of using same in the production of lipid particles.
  111. Eppstein Deborah A. (Menlo Park CA) Felgner Philip L. (Los Altos CA) Gadek Thomas R. (Oakland CA) Jones Gordon H. (Cupertino CA) Roman Richard B. (Fairhope AL), N-(www 상세보기
  • Cook P. Dan (Carlsbad CA) Ramasamy Kanda S. (Laguna Hills CA) Manoharan Muthiah (Carlsbad CA), N-2 substituted purines.
  • Eppstein Deborah A. (Menlo Park CA) Felgner Philip L. (Los Altos CA) Gadek Thomas R. (Oakland CA) Jones Gordon H. (Cupertino CA) Roman Richard B. (Fairhope AL), N-[1, (1-1)-dialkyloxy]-and N-[1, (1-1)-dialkenyloxy]-alk-1-yl-n,n,n-tetrasubstituted ammonium lipids and uses therefor.
  • Eppstein Deborah A. (Menlo Park CA) Felgner Philip L. (Los Altos CA) Gadek Thomas R. (Oakland CA) Jones Gordon H. (Cupertino CA) Roman Richard B. (Fairhope AL), N[www 상세보기
  • Ts\o Paul O. P. (2117 Folkstone Rd. Lutherville MD 21093) Miller Paul S. (225 Hopkins Rd. Baltimore MD 21212), Nonionic nucleic acid alkyl and aryl phosphonates and processes for manufacture and use thereof.
  • Cook Philip D. (Carlsbad CA) Sanghvi Yogesh S. (San Marcos CA), Nuclease resistant, pyrimidine modified oligonucleotides that detect and modulate gene expression.
  • Bischofberger Norbert W. (San Carlos CA) Matteucci Mark D. (Burlingame CA), Nucleic acid intercalating agents.
  • Haralambidis Jim (Victoria AUX), Nucleoside derivatives.
  • Meyer ; Jr. Rich B. (Woodinville WA) Adams A. David (Snohomish WA) Petrie Charles R. (Woodinville WA), Oligo (aa 상세보기
  • Letsinger Robert L. (Wilmette IL) Gryaznov Sergei M. (San Mateo CA), Oligodeoxyribonucleotides including 3′-aminonucleoside-phosphoramidate linkages and terminal 3′-amino groups.
  • Sanghvi Yogesh S. (Carlsbad CA) Cook Phillip D. (Carlsbad CA), Oligonucleoside linkages containing adjacent oxygen and nitrogen atoms.
  • Hecht Sidney M. (Charlottesville VA), Oligonucleotide N-alkylphosphoramidates.
  • Bischofberger Norbert (San Carlos CA) Kent Ken (Mountain View CA) Wagner Rick (Burlingame CA) Buhr Chris (Daly City CA) Lin Kuei-Ying (Fremont CA), Oligonucleotide analogs capable of passive cell membrane permeation.
  • Benner Steven A. (Grossmannstrasse 16 ; #7 CH-8049 Zurich CHX), Oligonucleotide analogs containing sulfur linkages.
  • Matteucci Mark (Burlingame CA), Oligonucleotide analogs with novel linkages.
  • Matteucci Mark (Burlingame CA), Oligonucleotide analogs with novel linkages.
  • Huie Edward M. (Wilmington DE) Trainor George L. (Wilmington DE), Oligonucleotide analogs with sulfamate linkages.
  • Weis Alexander Ludvik (Berwyn PA) Hausheer Frederick Herman (San Antonio TX) Chaturvedula Prasad Venkata Chala (Exton PA) Delecki Daniel Joseph (Radnor PA) Cavanaugh ; Jr. Paul Francis (West Chester , Oligonucleotide analogues containing phosphate diester linkage substitutes, compositions thereof, and precursor dinucleo.
  • Chaturvedula Prasad Venkata Chala (Exton PA), Oligonucleotide dimers with amide linkages replacing phosphodiester linkages.
  • Busch Harris (Houston TX) Bennett Clarence Frank (Carlsbad CA) Perlaky Laszlo (Houston TX) Saijo Yasuo (Sendai JPX) Busch Rose K. (Houston TX), Oligonucleotide modulation of cell growth.
  • Tullis Richard H. (La Jolla CA), Oligonucleotide therapeutic agent and method of making same.
  • Maag Hans (Menlo Park CA) Rose Samuel J. (Mountain View CA) Schmidt Beat (Baltschieder CHX), Oligonucleotides containing 4′-substituted nucleotides.
  • Gmeiner William H. (Omaha NE) Iversen Patrick L. (Omaha NE), Oligonucleotides containing 5-fluorouracil.
  • Froehler Brian (Belmont CA) Jones Robert J. (Daly City CA), Oligonucleotides containing 5-propynyl pyrimidines.
  • Cook Phillip D. (San Marcos CA) Ramasamy Kanda S. (Laguna Hills CA) Manoharan Muthiah (Carlsbad CA), Oligonucleotides containing N-2 substituted purines.
  • Cook Phillip D. (San Marcos CA) Hoke Glenn (Mt. Airy MD), Oligonucleotides having phosphorothioate linkages of high chiral purity.
  • Smith Lloyd M. (South Pasadena CA) Fung Steven (Palo Alto CA) Kaiser ; Jr. Robert J. (Glendale CA), Oligonucleotides possessing a primary amino group in the terminal nucleotide.
  • Froehler Brian (Belmont CA), Oligonucleotides with inverted polarity.
  • Lebleu Bernard (Montpellier FRX) Bayard Bernard (Castelnau Le Lez FRX), Oligonucleotides with modified phosphate and modified carbohydrate moieties at the respective chain termini.
  • Urdea Michael S. (Alamo CA) Horn Thomas (Berkeley CA), Oligonucleotides with selectably cleavable and/or abasic sites.
  • Imbach Jean-Louis (Montpellier FRX) Gosselin Gilles J. M. (Montpellier FRX), Oligonucleotides, a process for preparing the same and their application as mediators of the action of interferon.
  • Spielvogel Bernard F. (Raleigh NC) Sood Anup (Durham NC) Hall Iris H. (Chapel Hill NC) Shaw Barbara R. (Durham NC), Oligoribonucleoside and oligodeoxyribonucleoside boranophosphates.
  • Barascut Jean-Louis (Combaillaux FRX) Imbach Jean-Louis (Montpellier FRX), Oligothionucleotides.
  • Nielsen Peter E. (Hjortevanget 509 DK 2980 Kokkedal DKX) Buchardt Ole (Sondergardsvej 73 DK 3500 Vaerlose DKX) Egholm Michael (Johnstrup Alle 3 DK 1923 Frederiksberg DKX) Berg Rolf H. (Strandvaenget , Peptide nucleic acids.
  • Buchardt ; deceased Ole,DKX ; Buchardt ; legal representative by Dorte,DKX ; Egholm Michael ; Nielsen Peter Eigil,DKX ; Berg Rolf Henrik,DKX, Peptide nucleic acids having amino acid side chains.
  • Buchardt ; deceased Ole,DKX ; Buchardt ; representative by Dorte,DKX ; Egholm Michael ; Nielsen Peter Eigil,DKX ; Berg Rolf Henrik,DKX, Peptide nucleic acids having enhanced binding affinity, sequence specificity and solubility.
  • Hawley-Nelson Pamela ; Lan Jianqing ; Shih PoJen ; Jessee Joel A. ; Schifferli Kevin P., Peptide-enhanced cationic lipid transfections.
  • Hawley-Nelson Pamela ; Lan Jianqing ; Shih PoJen ; Jessee Joel A. ; Schifferli Kevin P. ; Gebeyehu Gulilat, Peptide-enhanced cationic lipid transfections.
  • Hawley-Nelson, Pamela; Lan, Jianqing; Shih, PoJen; Jessee, Joel A.; Schifferli, Kevin P.; Gebeyehu, Gulilat; Ciccarone, Valentina C.; Evans, Krista L., Peptide-enhanced transfections.
  • Pamela Hawley-Nelson ; Jianqing Lan ; PoJen Shih ; Joel A. Jessee ; Kevin P. Schifferli ; Gulilat Gebeyehu ; Valentina C. Ciccarone ; Krista L. Evans, Peptide-enhanced transfections.
  • Dwyer Brian Patrick ; Lehedev Alexandre V. ; Brown Bob Dale ; Schwartz David Aaron, Phosphonic acid-based cationic lipids.
  • Dwyer Brian Patrick ; Lehedev Alexandre V. ; Brown Bob Dale ; Schwartz David Aaron, Phosphonic acid-based cationic lipids.
  • Misiura Konrad (Lodz PLX) Gait Michael (Cambridge GB3), Phosphoramidite derivatives, their preparation and the use thereof in the incorporation of reporter groups on synthetic.
  • Ansell Steven Michial,CAX, Polyamide oligomers.
  • Choi Lewis S. L.,CAX ; Madden Thomas D.,CAX ; Webb Murray S.,CAX, Polyethylene glycol modified ceramide lipids and liposome uses thereof.
  • Heyes, James; MacLachlan, Ian; Ambegia, Ellen Grace, Polyethyleneglycol-modified lipid compounds and uses thereof.
  • Maddry Joseph A. (Birmingham AL) Reynolds Robert C. (Birmingham AL) Secrist John A. (Birmingham AL) Montgomery John A. (Birmingham AL) Crooks Peter A. (Lexington KY), Polynucleotide analogs containing sulfonate and sulfonamide internucleoside linkages.
  • Caruthers Marvin H. (Boulder CO) Marshall William S. (Boulder CO) Brill Wolfgang (Freiburg DEX) Nielsen John (Horsholm DKX), Polynucleotide phosphorodithioate.
  • Caruthers Marvin H. (Boulder CO) Marshall William S. (Boulder CO), Polynucleotide phosphorodithioates.
  • Urdea Michael S. (Alamo CA) Horn Thomas (Berkeley CA), Polynucleotide reagents containing modified deoxyribose moieties, and associated methods of synthesis and use.
  • Zhang Yuan-Peng ; Scherrer Peter,CAX ; Hope Michael J.,CAX, Preparation of lipid-nucleic acid particles using a solvent extraction and direct hydration method.
  • Weder Hans G. (E. Merck ; Postfach 4119 6100 Darmstadt 1 DEX) Zumbhl Otmar (Wolfenshiessen CHX) Schwendener Reto (Arosa CHX) Milsmann Manfred (Bielefeld DEX), Process and device for producing bilayer vesicles.
  • McGee Daniel Peter Claude (Boulder CO), Process for the preparation of 2′-O-alkyl purine phosphoramidites.
  • Schneider Michel (Geneva CHX), Process for the preparation of liposomes in aqueous solution.
  • Weis Alexander L. (Berwyn PA) Saha Ashis K. (Frazer PA) Hausheer Frederick H. (San Antonio TX), Process of linking nucleosides with a siloxane bridge.
  • Hawkins Mary E. (Potomac MD) Pfleiderer Wolfgang (Konstanz MD DEX) Davis Michael D. (Rockville MD) Balis Frank (Bethesda MD), Pteridine nucleotide analogs as fluorescent DNA probes.
  • Matteucci Mark D. (Burlingame CA) Jones Robert J. (Millbrae CA) Lin Kuei-Ying (Fremont CA), Pyrimidine derivatives for labeled binding partners.
  • Acevedo Oscar L. (San Diego CA) Hebert Normand (San Marcos CA), Pyrrolidine-containing monomers and oligomers.
  • Cech Thomas R. (Boulder CO) Zaug Arthur J. (Louisville CO) Been Michael D. (Boulder CO), RNA ribozyme polymerases, dephosphorylases, restriction endoribonucleases and methods.
  • Gebeyehu Gulilat ; Jessee Joel A., Reagents for intracellular delivery of macromolecules.
  • Gebeyehu, Guililat; Jessee, Joel A., Reagents for intracellular delivery of macromolecules.
  • Bowles, Henry M.; Langley, Theodore D., Relocatable mental function testing gateway.
  • Summerton James E. (Corvallis OR) Weller Dwight D. (Corvallis OR), Sequence-specific binding polymers for duplex nucleic acids.
  • Summerton James E. (Corvallis OR) Weller Dwight D. (Corvallis OR), Sequence-specific binding polymers for duplex nucleic acids.
  • Agrawal, Sudhir; Tang, Jinyan, Site-specific functionalization of oligodeoxynucleotides for non-radioactive labelling.
  • Van Ness Jeffrey (Bothell WA) Petrie Charles R. (Woodinville WA) Tabone John C. (Bothell WA) Vermeulen Nicolaas M. J. (Woodinville WA), Solid supports for nucleic acid hybridization assays.
  • Lenk Robert P. (Lambertville NJ) Fountain Michael W. (Plainsboro NJ) Janoff Andrew S. (Lawrenceville NJ) Ostro Marc J. (North Brunswick NJ) Popescu Micrea C. (Plainsboro NJ), Stable plurilamellar vesicles, their preparation and use.
  • Cook Phillip Dan (Carlsbad CA) Manoharan Muthiah (Carlsbad CA) Ramasamy Kanda S. (Laguna Hills CA), Substituted purines and oligonucleotide cross-linking.
  • Cook Phillip Dan (Carlsbad CA) Kawasaki Andrew Mamoro (Oceanside CA), Sugar modified oligonucleotides that detect and modulate gene expression.
  • Stadler Joan K. (3313 Oakland St. Ames IA 50010) Antonelli Nunzio M. (via Pezze del Sole ; 24 Bari ITX 70125), Synergistic method for host cell transformation.
  • Sproat Brian (Heidelberg DEX) Lamond Angus (Wiesenbach DEX) Paolella Giovanni (Gaiberg DEX), Synthetic catalytic oligonucleotide structures.
  • Debs Robert James (Mill Valley CA) Zhu Ning (El Cerrito CA), Transfection of lung via aerosolized transgene delivery.
  • Chu, Yongliang; Masoud, Malek; Gebeyehu, Gulilat, Transfection reagents.
  • Chu, Yongliang; Masoud, Malek; Gebeyehu, Gulilat, Transfection reagents.
  • Chu, Yongliang; Masoud, Malek; Gebeyehu, Gulilat, Transfection reagents.
  • Chu,Yongliang; Masoud,Malek; Gebeyehu,Gulilat, Transfection reagents.
  • Chu,Yongliang; Masoud,Malek; Gebeyehu,Gulilat, Transfection reagents.
  • Summerton, James E.; Weller, Dwight D., Uncharged morpholino-based polymers having achiral intersubunit linkages.
  • Summerton James E. (Corvallis OR) Weller Dwight D. (Corvallis OR), Uncharged morpolino-based polymers having phosphorous containing chiral intersubunit linkages.
  • Heather L. Davis CA; Joachim Schorr DE; Arthur M. Krieg, Use of nucleic acids containing unmethylated CpG dinucleotide as an adjuvant.
  • Highsmith, Roderick, Waste water disposal system.
  • 이 특허를 인용한 특허 (6)

    1. Chen, Jianxin; Ansell, Steven; Akinc, Akin; Dorkin, Joseph Robert; Qin, Xiaojun; Cantley, William; Manoharan, Muthiah; Rajeev, Kallanthottathil G.; Narayanannair, Jayaprakash K.; Jayaraman, Muthusamy, Lipid formulations.
    2. Ansell, Steven M.; Du, Xinyao, Lipids and lipid nanoparticle formulations for delivery of nucleic acids.
    3. Du, Xinyao, Lipids and lipid nanoparticle formulations for delivery of nucleic acids.
    4. Du, Xinyao; Ansell, Steven M., Lipids and lipid nanoparticle formulations for delivery of nucleic acids.
    5. Ciaramella, Giuseppe; Bouchon, Axel; Huang, Eric Yi-Chun, Nucleic acid vaccines.
    6. Ciaramella, Giuseppe; Bouchon, Axel; Huang, Eric Yi-Chun, Nucleic acid vaccines.

    문의처: helpdesk@kisti.re.kr전화: 080-969-4114

    AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

    AI-Helper 아이콘
    AI-Helper
    안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
    ※ AI-Helper는 부적절한 답변을 할 수 있습니다.

    선택된 텍스트

    맨위로